ANUH PHARMA LTD. - 506260 - Under Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Certificate dated 17th March, 2024 by Sanjay Doshi and Associates, Practicing Company Secretaries for the year ended 31st March, 2024 under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ANUH PHARMA LTD. - 506260 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2024 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent (RTA) of our Company. We request you to kindly take the same on record ANUH PHARMA LTD. - 506260 - Shareholder Meeting / Postal Ballot-Outcome of AGM
We have enclosed, pursuant to the BSE email dated 06th April, 2024, the covering letter for clarification along with the Revised outcome of 63rd Annual General Meeting of the shareholders meeting dated 18th August, 2024. ANUH PHARMA LTD. - 506260 - Announcement Under Regulation 30 (LODR)- Update On Investment In Houban Energy 5 Private Limited A Special Purpose Vehicle, For Solar Project Under Group Captive Model Through Open Access.
Disclosure regarding the Investment in Houban Energy 5 Private Limited a Special Purpose Vehicle for Solar Project under group captive model through open access instead of Houban Energy 11 Private Limited. The details of the above investment were submitted by the Company in Board meeting outcome dated 10th November, 2023. ANUH PHARMA LTD. - 506260 - Appointment of Company Secretary and Compliance Officer
Appointment of Company Secretary and Compliance Officer ANUH PHARMA LTD. - 506260 - Board Meeting Outcome for Board Meeting Held On 04Th April, 2024
To consider and approve the following agendas: 1. Appointment of Mr. Manan Jayesh Vadhan as Company Secretary and Compliance Officer of the Company w.e.f. 04th April, 2024. 2. Approval on investment in Huoban Energy 5 Private Limited (SPV) for 'Solar Project', under group captive model under open access ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Change in Directorate
Completion of tenure of Independent Director ANUH PHARMA LTD. - 506260 - Closure of Trading Window
Intimation regarding the Closure of Trading Window for dealing in securities of the Company shall remain closed from Monday, April 01, 2024 till completion of 48 hours after the declaration of Audited Financial Results of the Company for the year ended March 31, 2024. ANUH PHARMA LTD. - 506260 - Announcement Under Reg 30 (LODR)- Update
Approval from EDQM for CEP of Sulfadoxine API which is a Anti-Malarial Drug. ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation For Q3 2024.